An unusual response to 5‐azacitidine by a patient with chronic myelomonocytic leukemia

KEY CLINICAL MESSAGE: Hypomethylating agents may be useful in some but not all cases of myelodysplastic syndromes. In some versions of these conditions, this treatment may yield deleterious results. ABSTRACT: Chronic myelomonocytic leukemia (CMML) is considered to be a heterogeneous group of hematop...

Descripción completa

Detalles Bibliográficos
Autor principal: Islam, Anwarul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397479/
https://www.ncbi.nlm.nih.gov/pubmed/37546162
http://dx.doi.org/10.1002/ccr3.7748

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397479/
https://www.ncbi.nlm.nih.gov/pubmed/37546162
http://dx.doi.org/10.1002/ccr3.7748

Ejemplares similares